X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (104) 104
cancer (74) 74
cell biology (74) 74
humans (62) 62
physiology (47) 47
colorectal cancer (39) 39
biochemistry & molecular biology (32) 32
health aspects (32) 32
biomarkers (28) 28
metastases (27) 27
signal transduction (27) 27
animals (26) 26
expression (26) 26
apoptosis (25) 25
colorectal carcinoma (25) 25
pathogenesis (25) 25
prognosis (25) 25
tumors (24) 24
inflammation (23) 23
pharmacology & pharmacy (22) 22
cell proliferation (21) 21
care and treatment (20) 20
patients (20) 20
signaling (20) 20
development and progression (18) 18
breast cancer (17) 17
down-regulation (17) 17
female (17) 17
medical research (17) 17
metastasis (16) 16
risk (16) 16
activation (15) 15
inhibitors (15) 15
analysis (14) 14
antineoplastic agents - therapeutic use (14) 14
chemotherapy (14) 14
drug therapy (14) 14
medicine, experimental (14) 14
micrornas (14) 14
mirna (14) 14
pharmacology (14) 14
proteins (14) 14
breast (13) 13
microrna (13) 13
therapeutic applications (13) 13
wnt protein (13) 13
angiogenesis (12) 12
colon-cancer (12) 12
disease control (12) 12
gene expression (12) 12
receptors (12) 12
survival (12) 12
anticancer properties (11) 11
beta-catenin (11) 11
health risks (11) 11
medical prognosis (11) 11
signal transduction - drug effects (11) 11
curcumin (10) 10
diagnosis (10) 10
risk factors (10) 10
1-phosphatidylinositol 3-kinase (9) 9
breast-cancer (9) 9
cardiovascular diseases (9) 9
cell-proliferation (9) 9
deoxyribonucleic acid--dna (9) 9
drug resistance (9) 9
genes (9) 9
genetic variance (9) 9
in-vitro (9) 9
inhibition (9) 9
kinases (9) 9
metabolism (9) 9
pathways (9) 9
signaling pathway (9) 9
therapy (9) 9
toxicity (9) 9
tumor-growth (9) 9
colon cancer (8) 8
colorectal neoplasms - genetics (8) 8
colorectal neoplasms - pathology (8) 8
diagnostic systems (8) 8
mutation (8) 8
poor-prognosis (8) 8
ribonucleic acid--rna (8) 8
wnt signaling pathway (8) 8
adenosine (7) 7
akt protein (7) 7
cancer therapies (7) 7
carcinogenesis (7) 7
cardiovascular disease (7) 7
cells (7) 7
clinical trials (7) 7
colon (7) 7
gemcitabine (7) 7
genetic research (7) 7
genome-wide association (7) 7
growth (7) 7
immune system (7) 7
inflammation - metabolism (7) 7
invasiveness (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular Physiology, ISSN 0021-9541, 02/2018, Volume 233, Issue 2, pp. 866 - 879
Neuroblastoma (NB) with various clinical presentation is a known childhood malignancy. Despite significant progress in treatment of NB afflicted patients, high... 
miRNAs | neuroblastoma | anti‐GD2 drugs | anti-GD2 drugs | MATRIX-METALLOPROTEINASE 14 | PHYSIOLOGY | COLONY-STIMULATING FACTOR | MYCN-AMPLIFIED NEUROBLASTOMA | CELL BIOLOGY | MONOCLONAL-ANTIBODY 3F8 | SUPPRESSES CELL-MIGRATION | MULTIPLE-DRUG RESISTANCE | N-MYC | HIGH-RISK NEUROBLASTOMA | MULTIDRUG-RESISTANCE | MINIMAL RESIDUAL DISEASE | Predictive Value of Tests | Gangliosides - antagonists & inhibitors | Immunotherapy - methods | Humans | Neuroblastoma - genetics | Neuroblastoma - blood | Brain Neoplasms - genetics | Treatment Outcome | Antineoplastic Agents - therapeutic use | Brain Neoplasms - drug therapy | Gangliosides - immunology | Biomarkers, Tumor - blood | Molecular Diagnostic Techniques | Animals | Brain Neoplasms - immunology | Neuroblastoma - drug therapy | Brain Neoplasms - blood | Neuroblastoma - immunology | Biomarkers, Tumor - genetics | MicroRNAs - blood | MicroRNAs - genetics | Monoclonal antibodies | Biological products | MicroRNA | Neuroblastoma | Gangliosides | Immunotherapy | Drugs | Prognosis | Toxicity | Risk | Malignancy | Drug development | Carcinogenesis | Proteins | Carcinogens | miRNA | Diagnosis | Children | Risk groups | Therapeutic applications | Medical treatment | Health risks | Patients | Survival | Body fluids | Reviews | Medical prognosis | Biomarkers | Tumors | Index Medicus
Journal Article
Current Drug Targets, ISSN 1389-4501, 09/2019, Volume 20, Issue 11, p. 1129
Hepatocellular carcinoma (HCC) is a common cancer, and the second most common cause of cancer-associated death globally. One of the major reasons for this high... 
Body fluids | Liver cancer | MicroRNAs | Biomarkers | Hepatocellular carcinoma | miRNA | Diagnostic systems | Diagnosis | α-Fetoprotein | Survival
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2017, Volume 24, Issue 13, pp. 1321 - 1331
The phosphoinositide 3 kinase AKT mammalian target of rapamycin (PI3K-AKT-mTOR) signaling pathway is an important in the aetiology of pancreatic cancer (PC)... 
Resistance | Biomarkers | PDAC | Pancreatic cancer | PI3K-AKT pathway | MTOR inhibitor | HIGH-DOSE EPIRUBICIN | CHEMISTRY, MEDICINAL | PROSPECTIVE RANDOMIZED-TRIAL | biomarkers | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACUTE MYELOID-LEUKEMIA | OVARIAN-CANCER | resistance | LUNG-CANCER | pancreatic cancer | IN-VITRO | GLUCOSE-METABOLISM | ASCITES TUMOR-CELLS | ANTINEOPLASTIC DRUG LONIDAMINE | METASTATIC BREAST-CANCER | mTOR inhibitor | PHARMACOLOGY & PHARMACY | Pancreatic Neoplasms - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Pancreatic Neoplasms - pathology | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Autophagy - drug effects | Pancreatic Neoplasms - drug therapy | TOR Serine-Threonine Kinases - antagonists & inhibitors | Protein Kinase Inhibitors - chemistry | Signal Transduction - drug effects | Protein Kinase Inhibitors - therapeutic use | Protein Kinase Inhibitors - toxicity | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | TOR protein | Adenocarcinoma | Gemcitabine | Toxicity | AKT protein | Kinases | Genomic instability | Signal transduction | Cell cycle | Deoxyribonucleic acid--DNA | Cell survival | Stability | Therapeutic applications | Protein biosynthesis | Rapamycin | Metabolism | Gene expression | 1-Phosphatidylinositol 3-kinase | Signaling | Inhibitors | Protein synthesis | Medical prognosis | Wortmannin | Cancer | Apoptosis
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2018, Volume 24, Issue 37, pp. 4436 - 4444
Cardiovascular disease (CVD) is the first leading cause of morbidity and mortality in developing and developed countries. Circulating exosomes have recently... 
Cardiovascular disease | Biomarker | Extracellular vesicle | Exosome | Mortality | Morbidity | DIAGNOSIS | ANGIOGENESIS | MICRORNAS | biomarker | HEART | EXTRACELLULAR VESICLES | ENDOTHELIAL-CELLS | BIOLOGY | mortality | PHARMACOLOGY & PHARMACY | morbidity | CARDIOPROTECTION | PROTEINS | extracellular vesicle | exosome | COMMUNICATION
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2018, Volume 24, Issue 23, pp. 2701 - 2709
Colorectal Cancer (CRC) is one of the most common cancers with a high rate of morbidity and mortality worldwide. It has been demonstrated that epigenetic... 
colorectal cancer | DNA methylation | microRNA | Epigenetic | chemotherapeutic agents | histone acetylation | drug | HDAC INHIBITOR | HISTONE DEACETYLASE INHIBITOR | VALPROIC ACID | ISLAND METHYLATOR PHENOTYPE | COLON-CANCER | GENOMIC INSTABILITY | PHASE-II TRIAL | GASTRIC-CANCER | PHARMACOLOGY & PHARMACY | REFRACTORY SOLID TUMORS
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 07/2018, Volume 119, Issue 7, pp. 5996 - 6007
Journal Article